Internal Medicine · Waipahu, HI
NPI
1619980471
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
94-866 Moloalo St # 1b
Waipahu, HI, 96797
Phone (808) 677-5832
Groups this clinician bills Medicare through
Medicare paid, 2024
$36K
1,103 services
Medicare patients, 2024
106
Average age 74
Drug cost, 2024
$634K
8,245 prescriptions
Company payments, 2025
$21.91
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Maria C Ilar-Revilla was code 99213 (office e&m - established), 254 times for 92 patients. In total Maria C Ilar-Revilla billed 1,103 services in 18 codes, and Medicare paid $36K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-07-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 254 | 92 | $50.72 | $13K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 185 | 82 | $11.30 | $2,091 |
| 80061 Clinical Chemistry | Office | 176 | 68 | $12.72 | $2,238 |
| 99214 Office E&M - Established | Office | 140 | 77 | $64.79 | $9,070 |
| 82947 Clinical Chemistry | Office | 76 | 29 | $3.72 | $283 |
| 83036 Blood Count | Office | 55 | 39 | $9.11 | $501 |
| 99212 Office E&M - Established | Office | 52 | 42 | $30.36 | $1,579 |
| 87804 Immunoassay | Office | 37 | 16 | $14.28 | $528 |
| 87880 Immunoassay | Office | 34 | 29 | $15.11 | $514 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 22 | 22 | $122.48 | $2,695 |
| 90656 Vaccine Product | Office | 17 | 17 | $18.04 | $307 |
| G0008 Administration of influenza virus vaccine | Office | 14 | 14 | $33.52 | $469 |
| 87428 Infectious Agent Detection by DNA/RNA | Office | 14 | 14 | $64.99 | $910 |
| 93000 Electrocardiogram | Office | 11 | 11 | $8.68 | $95.44 |
By year: 2022 $26K for 548 services; 2023 $31K for 872 services; 2024 $36K for 1,103 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80061 Clinical Chemistry | 176 | 68 | $12.72 | $2,238 |
| 82947 Clinical Chemistry | 76 | 29 | $3.72 | $283 |
| 83036 Blood Count | 55 | 39 | $9.11 | $501 |
| 87804 Immunoassay | 37 | 16 | $14.28 | $528 |
| 87880 Immunoassay | 34 | 29 | $15.11 | $514 |
| 87428 Infectious Agent Detection by DNA/RNA | 14 | 14 | $64.99 | $910 |
Medicare prescription drug claims, 2024
In 2024, the drug Maria C Ilar-Revilla prescribed most often to Medicare patients was Atorvastatin Calcium, with 952 prescriptions and refills. In total Maria C Ilar-Revilla wrote 8,245 Medicare prescriptions that cost $634K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 952 | 2,766 | 312 | $13K |
| Losartan Potassium Generic | 801 | 2,287 | 257 | $9,897 |
| Lovastatin Generic | 524 | 1,521 | 173 | $7,450 |
| Amlodipine Besylate Generic | 519 | 1,491 | 164 | $4,750 |
| Metformin Hcl Generic | 477 | 1,395 | 157 | $3,517 |
| Felodipine Er Felodipine | 399 | 1,119 | 125 | $14K |
| Lisinopril Generic | 314 | 880 | 101 | $2,610 |
| Allopurinol Generic | 216 | 633 | 71 | $2,046 |
| Glipizide Er Glipizide | 180 | 521 | 53 | $2,387 |
| Clonidine Hcl Generic | 173 | 481 | 55 | $1,046 |
| Celecoxib Generic | 153 | 303 | 97 | $3,633 |
| Pioglitazone Hcl Generic | 151 | 438 | 64 | $2,681 |
| Glipizide Generic | 144 | 419 | 47 | $1,125 |
| Hydroxyzine Hcl Generic | 139 | 168 | 79 | $1,688 |
| Omeprazole Generic | 136 | 336 | 73 | $3,300 |
Brand drugs: 650 claims; generic drugs: 7,544 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Maria C Ilar-Revilla $21.91 ($21.91 in general payments such as food, travel and fees) from 1 company. The largest payer was GlaxoSmithKline, LLC. with $21.91.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 1 | $21.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.